Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study

NCT03724136 is registered in ClinicalTrials.gov with MD Stem Cells as lead sponsor.

NCT NCT03724136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03724136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study
Lead sponsor
MD Stem Cells
Phase
Not applicable
Overall status
Unknown status
Start date
October 24, 2018
Completion date
July 31, 2025
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer dementia, alzheimer disease, autism, autism spectrum disorder, autistic behavior, autistic disorder, current or active state, cadasil, chronic traumatic encephalopathy, dementia, mixed, dementia, multi-infarct, huntington's dementia, late limbic-predominant age-related tdp-43 encephalopathy, lewy body dementia with behavioral disturbance (disorder), lewy body disease, parkinson-dementia syndrome, traumatic brain injury, vascular dementia, wernicke korsakoff syndrome